Assessment of the Acceptability of a Humanoid Robot at Home for Children With Cochlear Implants - H2R2 (H2R2)

February 8, 2024 updated by: University Hospital, Toulouse
The quality of the rehabilitation of deafness in children with cochlear implantation is a major prognostic factor for the outcome on speech comprehension and oral expression. This rehabilitation is carried out cooperatively by the hospital cochlear implantation team, and by a speech therapist located near the child's home. The multi-weekly sessions represent a constraint for the child and his parents. Complementary training work at home would make it possible to balance the equity in the distribution of care in the territory, and should promote the progress of the child, who is more inclined to use a tool available at home.

Study Overview

Status

Completed

Detailed Description

The humanoid robot should allow an ecological approach to this additional rehabilitation. Before developing this approach, it is necessary to study the acceptability of the humanoid robot at home, both by the parents and by the cochlear implanted child. The main objective of this study is to assess the acceptability by the child and his family, of a humanoid robot installed at home for one month.

The secondary objectives are to describe the acceptability of the child and his family that is the relationship to technology, the intention of use, expectations, perceived utility, perception of the robot and facilitating conditions before then after 1 month of using the robot at home,

- describe the child's acceptability with respect to his experience, his fun and the emotions felt when he uses the robot at home

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Toulouse, France, 31059
        • University Hospital Toulouse - Service d'ORL, ORL pédiatrique et Otoneurologie
        • Sub-Investigator:
          • Marie Noelle Calmels, MD
        • Contact:
        • Principal Investigator:
          • Olivier Deguine, PU-PH
        • Sub-Investigator:
          • Mathieu MARX, PU- PH
        • Sub-Investigator:
          • Blandine Baladi, PH
        • Sub-Investigator:
          • Yohan Gallois, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 12 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Child aged 8 to 12, user of his cochlear implant with a favorable family environment,
  • Child implanted with at least one cochlear implant undergoing speech therapy rehabilitation, and monitored by the pediatric cochlear implant unit (UPIC) of the Toulouse University Hospital
  • Child and his family whose mother tongue is French
  • Affiliation to a social security scheme

Exclusion Criteria:

  • Cognitive or psychological inability or refusal of the participant to give written consent
  • Other sensory or motor deficit that may interfere with the use of the robot
  • Unstable psychiatric pathology
  • Child with both parents benefiting from a legal protection measure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Humanoid Robot
A humanoid robot will be installed for 30 days in children. It has a touchscreen tablet, allowing manual interaction complementing the voice interaction. The robot speaks, hears, and has facial and voice identification.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability of a humanoid robot
Time Frame: month 1
assess by the number of weekly hours during which the child uses the robot.
month 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Relationship to technology
Time Frame: month 1
Assessment by a set of questionnaires and standardized scales validated by the scientific community
month 1
Intention of use
Time Frame: month 1
Assessment by a set of questionnaires and standardized scales validated by the scientific community
month 1
Relationship with the robot
Time Frame: month 1
Assessment by a set of questionnaires and standardized scales validated by the scientific community
month 1
User experience
Time Frame: Month 1
Assessment by a set of questionnaires and standardized scales validated by the scientific community
Month 1
participants' expectations
Time Frame: Month 1
Measurement by sentence completion which consists of giving the beginning of a sentence and letting the user complete the rest of the sentence
Month 1
3Emethod
Time Frame: Month 1
Evaluation of emotions in the form of a drawing with a speech bubble and a thought bubble.
Month 1
classification of activities
Time Frame: Month 1
classification according to various criteria (good functioning, fun, ease of use)
Month 1
Feedback
Time Frame: Month 1
with a Semi-structured interview on the use of the robot
Month 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Olivier DEGUINE, PH, University Hospital, Toulouse

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 17, 2021

Primary Completion (Actual)

March 29, 2023

Study Completion (Actual)

March 29, 2023

Study Registration Dates

First Submitted

March 31, 2021

First Submitted That Met QC Criteria

April 2, 2021

First Posted (Actual)

April 5, 2021

Study Record Updates

Last Update Posted (Actual)

February 12, 2024

Last Update Submitted That Met QC Criteria

February 8, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RC31/20/0250
  • 2020-A01989-30. (Other Identifier: ID-RCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cochlear Implantation

Clinical Trials on Interaction with humanoid robot

3
Subscribe